Now showing items 1-10 of 76
Biocompatible microemulsion modifies the pharmacokinetic profile and cardiotoxicity of doxorubicin
Doxorubicin (DOX) is an anthracycline antibiotic with a broad antitumor spectrum. However, the clinical use of DOX is limited because of its cardiotoxicity, a dose-dependent effect. Colloidal drug delivery systems, such ...
Effect of pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non–ST segment elevation with Type-2 diabetes
The acute coronary syndrome is a consequence of coronary artery disease. Creatine Kinase MB is a cardiac biochemical marker used in the diagnosis and risk stratification of patients. The diabetes is a pathology associated ...
Comparison of MB fraction of creatine kinase mass and troponin I serum levels with necropsy findings in acute myocardial infarction
(EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, 2008)
Serum levels of troponin and heart-related fraction of creatine kinase (CK-MB) mass are used as diagnostic and prognostic criteria in myocardial infarction, but the relation between those levels and-the necropsy-determined ...
Waist circumference, but not body mass index, is a predictor of ventricular remodeling after anterior myocardial infarction
Objective: The impact of obesity on ventricular remodeling after myocardial infarction (MI) is still poorly understood. Therefore, the aim of this study was to evaluate the role of waist circumference (WC) and body mass ...
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction
(LIPPINCOTT WILLIAMS & WILKINSPHILADELPHIA, 2012)
Objectives Predictors of adverse outcomes following myocardial infarction (MI) are well established; however, little is known about what predicts enzymatically estimated infarct size in patients with acute ST-elevation MI. ...